Stable nanoreporters
View Patent ↗The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to improved, stable nanoreporter probes that are capable of binding to and identifying target molecules based on the probes' uniquely detectable signal. Methods for identifying target-specific sequences for inclusion in the probes are also provided, as are methods of making and using such probes. Polynucleotide sequences of certain nanoreporter components are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
1. A population of uniquely labeled nanoreporter probes, wherein each uniquely labeled nanoreporter probe comprises:
i) a unique target-specific region;
ii) a region comprising a unique, designed nanoreporter
wherein said unique, designed nanoreporter comprises a single-stranded nucleic acid backbone, said single-stranded nucleic acid backbone comprising three or more label attachment regions covalently attached together in a unique linear combination, wherein each label attachment region of each single stranded nucleic acid backbone is different from the other label attachment regions in that same single stranded nucleic acid backbone,
wherein the label attachment regions are selected from a population of designed polynucleotide sequences, and wherein the label attachment regions are selected from the group consisting of SEQ ID NOs: 1-24,
wherein the designed polynucleotide sequence is hybridized to a complementary polynucleotide sequence having attached thereto one or more detectable molecules;
wherein each complementary polynucleotide sequence has designated a specific detectable molecule; and
wherein each uniquely labeled nanoreporter probe has a detectable signal that distinguishes it from other uniquely labeled nanoreporter probe in said population of uniquely labeled nanoreporter probes.
2. The population of uniquely labeled nanoreporter probes of claim 1 wherein said nanoreporter probe further comprises a constant region, wherein the constant region comprises a plurality of repeat nucleotide sequences.
3. The population of uniquely labeled nanoreporter probes of claim 1 wherein the complementary polynucleotide sequence comprises a RNA polynucleotide sequence.
4. The population of uniquely labeled nanoreporter probes of claim 3 wherein the RNA polynucleotide sequence comprises at least one amino-allyl modified uracil base.
5. The population of uniquely labeled nanoreporter probes of claim 4 wherein the detectable molecule is attached to the amino-allyl modified uracil base.
6. The population of uniquely labeled nanoreporter probes of claim 3 wherein the RNA polynucleotide sequence comprises a plurality of amino-allyl modified uracil bases that are spaced at about an average of every 8 to 16 bases in said RNA polynucleotide sequence.
7. The population of uniquely labeled nanoreporter probes of claim 6 wherein the detectable molecule is attached to each of the amino-allyl modified uracil bases.
8. The population of uniquely labeled nanoreporter probes of claim 1 wherein the detectable molecules are fluorescent dyes.
9. The population of uniquely labeled nanoreporter probes of claim 1 where the melting temperature (Tm) of said complementary polynucleotide sequences when hybridized to its label attachment regions is about 80°C or higher.
10. The population of uniquely labeled nanoreporter probes of claim 1 , wherein the uniquely labeled nanoreporter probe does not comprise any stable secondary structures.
11. The population of uniquely labeled nanoreporter probes of claim 1 , wherein the uniquely labeled nanoreporter probe does not comprise any inverted repeats of 7 nucleotides or greater.
12. The population of uniquely labeled nanoreporter probes of claim 1 , wherein the uniquely labeled nanoreporter probe does not comprise any direct repeats of 7 nucleotides or greater.
13. A uniquely labeled nanoreporter probe comprising:
i) a unique target-specific region; and
ii) a region comprising three or more label attachment regions covalently attached together in a linear combination,
wherein each selected label attachment region is different from the other selected label attachment regions, and wherein the label attachment regions are selected from the group consisting of SEQ ID NOs: 1-24, and
wherein each label attachment region is hybridized to a complementary polynucleotide sequence having attached thereto one or more detectable molecules, and wherein the complementary polynucleotide sequence has a G/C ratio of at least 1/1.
14. The uniquely labeled nanoreporter probe of claim 13 wherein the complementary polynucleotide sequence has a G/C ratio of about 3/2.
15. The uniquely labeled nanoreporter probe of claim 13 further comprising a constant region, wherein the constant region comprises a plurality of repeat nucleotide sequences.
16. The uniquely labeled nanoreporter probe of claim 13 wherein the complementary polynucleotide sequence comprises a RNA polynucleotide sequence.
17. The uniquely labeled nanoreporter probe of claim 16 wherein the RNA polynucleotide sequence comprises at least one amino-allyl modified uracil base.
18. The uniquely labeled nanoreporter probe of claim 17 wherein the detectable molecule is attached to the amino-allyl modified uracil base.
19. The uniquely labeled nanoreporter probee of claim 16 wherein the RNA polynucleotide sequence comprises a plurality of amino-allyl modified uracil bases that are spaced at about an average of every 8 to 16 bases in said RNA polynucleotide sequence.
20. The uniquely labeled nanoreporter probe of claim 19 wherein the detectable molecule is attached to each of the amino-allyl modified uracil bases.
21. The uniquely labeled nanoreporter probe of claim 13 wherein the detectable molecules are fluorescent dyes.
22. A kit for preparing at least one uniquely labeled nanoreporter comprising:
a) at least three label attachment regions each wherein each label attachment region is different from the other label attachment regions, and wherein the label attachment regions are selected from the group consisting of SEQ ID NOs: 1-24; and
b) at least three complementary polynucleotide sequences having attached thereto a detectable molecule, wherein the complementary polynucleotide sequences has a G/C ratio of at least 1/1.
23. The kit of claim 22 further comprising at least three target specific probes.